The efficacy of the malarial vaccine SPf66
Von Sonnenburg, F.
Deutsche Medizinische Wochenschrift 120(16): 590-591
1995
ISSN/ISBN: 0012-0472 PMID: 7736955 Document Number: 452063
Document emailed within 1 workday
Related Documents
De Cock, K.M.; Hodgen, A.N.; Jupp, R.A.; Slavin, B.; Siongok, T.K.; Rees, P.H.; Lucas, S.B. 1986: Immunoglobin M and malarial antibody levels in hyper-reactive malarial splenomegaly Journal of Tropical Medicine and Hygiene 89(3): 119-121Root, E.D.; Lucero, M.; Nohynek, H.; Anthamatten, P.; Thomas, D.S.K.; Tallo, V.; Tanskanen, A.; Quiambao, B.P.; Puumalainen, T.; Lupisan, S.P.; Ruutu, P.; Ladesma, E.; Williams, G.M.; Riley, I.; Simões, E.A.F. 2014: Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children Proceedings of the National Academy of Sciences of the United States of America 111(9): 3520-3525
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Nambei, W.S.; Gbagba, F.E.; Ndémanga, J.; Doui-Doumgba, K.; Diallo, T.O.; Ndadjimbaye, V.; Flori, P.; Perraut, R.; Garraud, O. 2005: Efficacy comparison between anti-malarial drugs in Africans presenting with mild malaria in the Central Republic of Africa: a preliminary study Parasite 12(1): 73-77
Doumbo, O.; Traore, S.F.; Sow, Y.; Dembele, M.; Soula, G.; Coulibaly, A.; Dolo, A.; Sangare, O.; Koita, O.; Pichard, E. 1991: Impact of curtains and blankets impregnated with permethrin on the malarial indicators and the number of malarial attacks per child in a village in an area hyperendemic for malaria on the Malian savannah (preliminary results of the first year study) Bulletin de la Societe de Pathologie Exotique 84(5 Part 5): 761-774
Wheeler, C.M.; Castellsagué, X.; Garland, S.M.; Szarewski, A.; Paavonen, J.; Naud, P.; Salmerón, J.; Chow, S.-N.; Apter, D.; Kitchener, H.; Teixeira, J.úl.C.; Skinner, S.R.; Jaisamrarn, U.; Limson, G.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; Bosch, F.X.; Harper, D.M.; Huh, W.; Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.; Dubin, G.; Lehtinen, M.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N.; Kyha-österlund, L.; Lehtinen, M.; Levanen, H.; Lönn 2012: Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 100-110
Gathirwa, J.W.; Rukunga, G.M.; Njagi, E.N.M.; Omar, S.A.; Mwitari, P.G.; Guantai, A.N.; Tolo, F.M.; Kimani, C.W.; Muthaura, C.N.; Kirira, P.G.; Ndunda, T.N.; Amalemba, G.; Mungai, G.M.; Ndiege, I.O. 2008: The in vitro anti-plasmodial and in vivo anti-malarial efficacy of combinations of some medicinal plants used traditionally for treatment of malaria by the Meru community in Kenya Journal of Ethnopharmacology 115(2): 223-231
Marshall, V. 1983: Efficacy of Leptospira vaccine Journal of the American Veterinary Medical Association 183(1): 12; 34
Smith, C.K. 1986: More on vaccine efficacy trial Journal of the American Veterinary Medical Association 189(8): 854-856
Ashkenazi, S.; Danon, Y.L.; Nitzan, M. 1987: A new pertussis vaccine--necessity and efficacy Harefuah 113(9): 264-266
Pengloan, J.; Maupas, P.; Goudeau, A.; Coursaget, P.; Drucker, J.; Bagros, P.; Grenier, B. 1977: Efficacy of vaccine against hepatitis B; epidemiological data Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 14: 215-221
Jin, P.; Li, J.; Zhou, Y.; Zhu, F. 2015: Immunological surrogate endpoints to evaluate vaccine efficacy Zhonghua Yu Fang Yi Xue Za Zhi 49(12): 1110-1114
Dave, K.H.; Mandke, V.B. 1987: Efficacy of wet ice as a refrigerant for transport of oral polio vaccine Indian Journal of Medical Research 85: 715-716
Morris, L.; van der Ryst, E.; Gray, C.; Williamson, C. 1997: Should South Africa be preparing for HIV-1 vaccine efficacy trials? South African Medical Journal 87(3): 285-290
De Bruyn, G.; Martinson, N.A.; Nkala, B.D.; Tshabangu, N.; Shilaluka, G.; Kublin, J.; Corey, L.; Gray, G.E. 2009: Uptake of male circumcision in an HIV vaccine efficacy trial Journal of Acquired Immune Deficiency Syndromes 51(1): 108-110
Afzal, M.; Ahmad, I. 1990: Efficacy of an inactivated vaccine against hydropericardium syndrome in broilers Veterinary Record 126(3): 59-60
Geerligs, H.J.; Weststrate, M.W.; Pertile, T.L.; Rodenberg, J.; Kumar, M.; Chu, S. 1999: Efficacy of a combination vaccine containing MDV CVi 988 strain and HVT against challenge with very virulent MDV Acta Virologica 43(2-3): 198-200
Steves, F.E.; Baker, J.D.; Hein, V.D.; Miller, T.A. 1973: Efficacy of a hookworm (Ancylostoma caninum) vaccine for dogs Journal of the American Veterinary Medical Association 163(3): 231-235
Mary-Krause, M.; Mary, J.Y.; Valleron, A.J. 1993: Conditions of validation and use of the screening method for vaccine efficacy evaluation Revue d'Epidemiologie et de Sante Publique 41(2): 155-160
Sørensen, K.J.; Madsen, P.; Lei, J.C. 1988: Efficacy of an inactivated porcine parvovirus (PPV) vaccine under field conditions Acta Veterinaria Scandinavica 29(3-4): 295-302